Navigation Links
Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
Date:5/9/2011

ALISO VIEJO, Calif., May 9, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Elona Kogan, Esq. to the position of vice president of legal affairs.

"At this time of growth and transition to a commercial stage biopharmaceutical company, Elona's legal, regulatory and business expertise will be a valuable asset to our organization," said Keith A. Katkin, president and CEO of Avanir. "The executive team and I are pleased to have Elona's extensive experience and expert counsel as we move ahead with our exciting new endeavors."

Ms. Kogan has over 17 years of experience covering areas of commercial and regulatory compliance, patient assistance programs, privacy issues, contracting, litigation and corporate governance. Most recently Ms. Kogan was associate general counsel and privacy officer at King Pharmaceuticals, where she was the primary legal liaison for corporate strategic and tactical commercial initiatives. Previously, Ms. Kogan was counsel for U.S. Medicines at Bristol-Myers Squibb. Prior roles included positions at Bergen Brunswig Corporation, and Epstein, Becker & Green. Ms. Kogan earned her J.D. degree from Southwestern University and her B.A. degree in Economics from Columbia University.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ is a trademark owned by Avanir Pharmaceuticals, Inc.

©2011 A
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Avanir Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
2. Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
3. Avanir Pharmaceuticals to Present Data at the American Academy of Neurology Annual Meeting
4. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
5. Avanir Pharmaceuticals to Present at Three Conferences in March
6. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
7. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
8. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
9. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
10. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Virginia , 11. Juli 2014 ... von Kameras für die molekulare Bildgebung, ... hat heute die CE-Zulassung für sein ... CE-Zeichen kann Dilon das Produkt jetzt ... auf den Großteil der europäischen Länder ...
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
(Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Fenwick & West, a leading technology and life sciences ... joined the firm as a partner in its Life Sciences ... clients as a strategic counselor on a broad range of ... and secretary at AVI BioPharma, Ms. Toshav is based in ...
... 14, 2012 Medical device recalls increased more than ... more than five times as many units than the ... released today. Products impacted by the increase ... Consumer product recalls also increased in the first quarter ...
Cached Medicine Technology:Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 3
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has been ... Food & Drug Administration’s (FDA) Obstetrics and ... explore ways to mitigate the cancer risks associated ... invasive gynecological surgeries. According to a report published ...
(Date:7/11/2014)... Datalogic brings a new and innovative ... wide. With their new Gryphon GD4400 and ... the devastating MRSA, which claimed 5,500 lives, becomes more ... 2D and the Gryphon GM4400-HC 2D readers can scan ... read barcodes off of troublesome LCD monitors, smartphones, and ...
(Date:7/11/2014)... people with sex addiction, pornography affects the brain in ... addicts as they consume drugs, a new study finds. ... patients who have compulsive sexual behavior and healthy volunteers. ... Dr. Valerie Voon, of the University of Cambridge in ... research involved 19 men with sex addiction and a ...
(Date:7/11/2014)... Ticket Down is a reliable source for ... When it comes to the summer concert schedule, it just isn’t ... is one of the biggest names in country music and one ... out on his “That’s My Kind of Night” tour featuring Lee ... be making through the rest of the summer and into the ...
(Date:7/11/2014)... According to a new market research ... Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application ... Transportation, Agriculture) & Geography - Global Trends & Forecasts ... Things market was worth $1029.5 Billion in 2013, and ... an estimated CAGR of 4.08% from 2014 to 2020. ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4
... 50% of fertility clinics in the US are allowing parents ... It also found that in 9 percent of the cases ... ,Dr. William Gibbons, president of the Society for Assisted ... most cases the gender selection tests were being performed for ...
... Refugees residing on temporary protection visas (TPVs) are ... mental health problems than those with permanent protection ... psychiatrists have revealed. ,Anxiety, post-traumatic stress ... for TPV holders than for PPV holders, mental ...
... steady partners, according to a new study. One in 10 men ... admitted that it was a regular habit. // ,"Approximately ... relationship," said Dr Tamsin Groom, of the Sandyford Initiative in Glasgow. ... used condoms in most cases except when they were out of ...
... vaccines to prevent severe gastroenteritis should now be made ... the latest issue of the Medical Journal of Australia. ... having such an effective tool to prevent a common, ... and Ruth Bishop say in an editorial. ...
... kills hundreds of thousands worldwide, infect by stealth. ... the very immune system// cells the body relies ... ,Just how Salmonella escapes detection by macrophages, ... infection, has seemed impossibly complicated, a needle-in-a-haystack proposition ...
... The U.S. physician workforce has released a study saying ... aging US population. Researchers from the University// of Utah ... said that the health needs of the population were ... report, titled "Family Physician Workforce Reform: Recommendations of the ...
Cached Medicine News:Health News:Detention, Uncertainty take their Toll on the Mental Health of Refugees 2Health News:Experts Call for Rotavirus Vaccine for All 2Health News:An Infectious Agent of Deception, Exposed Through Proteomics 2Health News:Call To Increase Family Physicians 2Health News:Call To Increase Family Physicians 3
... Flash Cards is designed ... heart, veins, and arteries ... It uses the time ... from BryanEdwards.com and displays ...
... Consult is the perfect quick consult ... diagnosis and management of both common ... of chest pain to the management ... quick reference makes the most of ...
... Unbound Surgery, published by ... innovative digital resource that ... and leading edge technology. ... that is specifically engineered ...
... guide to the management of ... offers a response from leading ... the more common, and often ... cardiology. It is a "how-to" ...
Medicine Products: